40776 Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 

Competitive Advantages 

• This invention comprises a method 

of treating HIV using therapeutics 

geared toward viral release and entry, 

distinguishing it from other antiviral 

candidates with its method of action. 

• CD62L is a new target for HIV 

Development Stage 

• In vitro studies; Proof-of-concept 

studies. 

Inventors 

Peter Sun, NIAID, NIH 

Joseph Kononchik, NIAID, NIH 

Joanna Ireland, NIAID, NIH 

Ruiping Wang, NIAID, NIH 

Intellectual Property: HHS Reference 

No. E–261–2015/0—PCT No. PCT/ 

US2016/068713 filed 12/27/2016. 

Licensing Contact: Chris Kornak, 240– 

627–3705, Chris.Kornak@nih.gov. 

Collaborative Research Opportunity: 

The Technology Transfer and 

Intellectual Property Office (TTIPO) is 

seeking parties interested in 

collaborative research to further codevelop this technology by identifying 

pharmacological compounds inhibiting 

CD62L shedding by using high 

throughput compound screening. For 

collaboration opportunities, please 

contact Chris Kornak, 240–627–3705, 

Chris.Kornak@nih.gov. 

Dated: August 15, 2017. 

Suzanne Frisbie, 

Deputy Director, Technology Transfer and 

Intellectual Property Office, National Institute 

of Allergy and Infectious Diseases. 

[FR Doc. 2017–18137 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director; Notice of Charter 

Renewal 

It is determined that the Advisory 

Committee to the Deputy Director for 

Intramural Research, National Institutes 

of Health, is in the public interest in 

connection with the performance of 

duties imposed on the National 

Institutes of Health by law, and that 

these duties can best be performed 

through the advice and counsel of this 

group. 

In accordance with Title 41 of the 

U.S. Code of Federal Regulations, 

Section 102–3.65(a), notice is hereby 

given that the Charter for the Advisory 

Committee to the Deputy Director for 

Intramural Research, National Institutes 

of Health, was renewed for an 

additional two-year period on August 

15, 2017. 

Inquiries may be directed to Jennifer 

Spaeth, Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail code 4875), Telephone (301) 496– 

2123, or spaethj@od.nih.gov. 

Dated: August 18, 2017. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18197 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Behavior and 

Social Science of Aging Review Committee. 

Date: October 5–6, 2017. 

Time: 3:00 p.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Kimberly Firth, Ph.D., 

National Institute on Aging, Gateway 

Building, 7201 Wisconsin Avenue, Suite 

2C212, Bethesda, MD 20892, 301–402–7702, 

kimberly.firth@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 23, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–18199 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection: 60-Day Comment 

Request; Generic Clearance To 

Support the Safe to Sleep® Campaign 

at the Eunice Kennedy Shriver National 

Institute for Child Health and Human 

Development (NICHD) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development (NICHD), the National 

Institutes of Health (NIH) will publish 

periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Lorena Kaplan, M.P.H., CHES, 

Office of Communications, Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development, 

National Institutes of Health, 31 Center 

Drive, Room 2A32, Bethesda, Maryland 

20892, or call non-toll free number (301) 

496–6670 or Email your request, 

including your address to 

lorena.kaplan@nih.gov. Formal requests 

for additional plans and instruments 

must be requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

ways to enhance the quality, utility, and 

clarity of the information to be 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices 40777 

collected; and (4) ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Proposed Collection Title: Generic 

Clearance to Support the Safe to Sleep®

Campaign at the Eunice Kennedy 

Shriver National Institute for Child 

Health and Human Development 

(NICHD), 0925–0701 Reinstatement 

without Change Eunice Kennedy 

Shriver National Institute of Child 

Health and Human Development 

(NICHD), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: This is a request to reinstate 

without change a generic clearance that 

would be used for submissions specific 

to the Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development (NICHD) Safe to Sleep®

(STS) public education campaign. 

Submissions for the STS campaign will 

be used to assess the understanding and 

reach of STS campaign materials and 

messages, and to monitor and improve 

campaign activities such as training 

workshops and overall implementation. 

The purpose of this information 

collection is to monitor and modify 

campaign activities, to plan future 

campaign activities, to develop 

messages and materials, and to develop 

distribution and outreach strategies that 

are effective at communicating their 

message to bring about the intended 

response, awareness, and/or behavioral 

change for the target audiences. This 

generic clearance will enable the NICHD 

to: (1) More efficiently assess the 

implementation of campaign activities; 

(2) better understand the target 

audiences’ knowledge, attitudes, and 

beliefs toward STS messages and 

materials; (3) better understand how the 

campaign activities have influenced the 

target audiences’ behaviors and 

practices; and (4) monitor and improve 

activities such as trainings, materials, 

and messages. Having a way to gather 

feedback on the STS campaign activities 

is critical to assessing the reach and 

effect of campaign efforts. Data collected 

for the campaign can inform where 

future STS campaign resources can 

produce the most meaningful results. 

Data collected for the STS campaign 

generic clearance will be used by a 

number of audiences, including STS 

campaign staff, NICHD leadership, STS 

campaign collaborators, Federal SUID/ 

SIDS Workgroup members, SUID/SIDS 

stakeholders, clinical and maternal and 

child health professionals. These 

audiences may use the information 

collections to: (1) Develop new 

campaign messages, materials, and/or 

training curricula; (2) monitor and 

improve campaign activities; (3) make 

decisions about campaign activities; (4) 

inform current campaign activities; and 

(5) inform and/or change practices and 

behaviors of program participants. 

Examples of the types of information 

collections that could be included under 

this generic clearance include: Focus 

groups and in-depth interviews with 

parents/caregivers and/or health 

professionals to get feedback on 

distribution and outreach activities, 

and/or campaign messages; and Surveys 

with parents/caregivers and/or health 

professionals to: (1) Assess the 

usefulness of the new STS campaign 

materials, including print and online 

materials and a video, (2) track outreach 

experiences of program participants, (3) 

assess training participants’ changes in 

knowledge related to safe infant sleep 

behavior and implementation of 

outreach methods taught, and (4) assess 

program participants’ resource needs. 

The sub-studies for this generic 

clearance will be small scale, designed 

to obtain results frequently and quickly 

to guide campaign development and 

implementation, inform campaign 

direction, and be used internally for 

campaign management purposes. 

NICHD’s current scope and capacity for 

STS generic sub-studies is non-existent 

and this request would fill this gap. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

12,920. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondents 

Number of 

respondents 

Number 

of responses 

per 

respondent 

Average 

burden 

per response 

(in hours) 

Total annual 

burden hours 

Focus Groups ....................................................... General Public .............. 45 1 1 45 

Interviews .............................................................. General Public .............. 45 1 1 45 

Pre/Post Tests ...................................................... General Public .............. 3,500 2 15/60 1,750 

Pre/Post Tests ...................................................... Health Professionals .... 20,000 2 15/60 10,000 

Surveys ................................................................. Health Professionals .... 2,000 1 30/60 1,000 

Tracking/Feedback Form ...................................... Health Educators .......... 40 2 1 80 

Total ............................................................... ....................................... 25,630 49,170 ........................ 12,920 

Dated: August 23, 2017. 

Jennifer Guimond, 

Project Clearance Liaison, Eunice Kennedy 

Shriver National Institute of Child Health and 

Human Development, National Institutes of 

Health. 

[FR Doc. 2017–18196 Filed 8–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR: 

Development of Appropriate Pediatric 

Formulations and Pediatric Drug Delivery 

Systems. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES